Snowball logo
logo
4120

Orient Europharma Co Ltd

4120 β€’ TWO
NT$49.00NT$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
4,7674,730.54,591.94,391.34,595.14,589.8
COGS
2,616.32,698.22,444.72,325.12,357.82,311.1
Gross Profit
2,150.72,032.32,147.22,066.22,237.32,278.7
Operating Expenses & Income
Operating Income
(98.15)(149.9)72.1413.32(298.8)(202.9)
Total Operating Expenses
4,865.24,880.44,519.74,3784,893.94,792.7
R&D Expenses
331.1259.8206.6242.2558.4479.6
Selling General & Admin Expenses
1,917.81,922.41,868.51,810.61,977.72,002
Earnings from Continuing Operations
Interest Expense
(38.04)(69.53)(106.1)(107.2)(74.06)(69.63)
Interest Income
11.8520.9650.8648.8734.3836.03
Income Tax Expense
10.47(32.77)----
Net Income
Net Income
120.2(310.8)143.9(283.9)(567.4)(438.6)
Supplemental
EBIT
(95.68)(149.5)----
EBITDA
313.9(64.29)----
In millions of TWD, except % and values per 1 share